Global Pharmaceuticals & Biotech Nano Cap Stocks

BioLASCO Taiwan

Market Cap: NT$858.0m

Provides bio-materials and surgical services in Taiwan and internationally.

Clene

Market Cap: US$28.7m

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.

Modern Chinese Medicine Group

Market Cap: HK$222.0m

An investment holding company, engages in the production and sale of proprietary Chinese medicines for elderlies and middle aged in the People's Republic of China.

Scilex Holding

Market Cap: US$28.1m

Focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain.

Kimia Biosciences

Market Cap: ₹2.4b

Manufactures and sells active pharmaceutical ingredients (APIs) in India.

Decibel Cannabis

Market Cap: CA$37.5m

An integrated cannabis company, engages in the cannabis cultivation in Canada.

Labiana Health

Market Cap: €23.7m

Develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, and internationally.

PeterLabs Holdings Berhad

Market Cap: RM 112.8m

An investment holding company, engages in manufacturing, distribution, trading, and export of animal health and nutrition products for the livestock industry in Malaysia and internationally.

Daré Bioscience

Market Cap: US$26.3m

A biopharmaceutical company, develops therapies in the areas of contraception, reproductive health, menopause, fertility, and sexual and vaginal health in the United States.

Cynata Therapeutics

Market Cap: AU$40.7m

Engages in the development and commercialization of proprietary induced pluripotent stem cell and mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia.

Vext Science

Market Cap: CA$35.6m

Through its subsidiaries, provides integrated agricultural technology, services, and property management services in the cannabis industry in the United States.

Seach Medical Group

Market Cap: ₪91.0m

Manufactures and sells medicinal cannabis products worldwide.

Curis

Market Cap: US$25.7m

A biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States.

Corline Biomedical

Market Cap: SEK 244.9m

Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.

PuraPharm

Market Cap: HK$197.5m

An investment holding company, engages in research, development, production, and sale of concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally.

SynBiotic

Market Cap: €21.9m

Engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety.

iAnthus Capital Holdings

Market Cap: CA$33.7m

Owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States.

Cryosite

Market Cap: AU$36.6m

Provides outsourced clinical trials logistic services in Australia.

Ulisse Biomed

Market Cap: €20.3m

A healthcare biotech company, develops, produces, and markets vitro diagnostic medical devices in Italy.

Daesung Microbiological Labs

Market Cap: ₩31.8b

Manufactures and sells vaccines for swine, poultry, canine, cattle, and fish in South Korea.

Kontafarma China Holdings

Market Cap: HK$178.8m

An investment holding company, manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediate in Mainland China, Singapore, Taiwan, and internationally.

MIRA Pharmaceuticals

Market Cap: US$22.7m

Operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders.

Bilcare

Market Cap: ₹1.9b

Provides pharmaceutical packaging research solutions in India and internationally.

Enlivex Therapeutics

Market Cap: US$22.3m

Operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel.

Little Green Pharma

Market Cap: AU$33.4m

Engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and Europe.

1CM

Market Cap: CA$29.4m

Operates as a multi-jurisdictional cannabis company in Canada.

Valbiotis

Market Cap: €18.4m

Engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France.

China Health Group

Market Cap: HK$160.3m

An investment holding company, provides research and development services of drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China.

C21 Investments

Market Cap: CA$27.1m

An integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States.

WooGene B&G

Market Cap: ₩26.7b

Engages veterinary medicines, microbial technology, and vaccines business in South Korea and internationally.

IM Cannabis

Market Cap: CA$26.2m

Engages in breeding, growing, and supply of medical cannabis products in Israel and Germany.

Devonian Health Group

Market Cap: CA$25.2m

Engages in the development of botanical drugs.

SoftOx Solutions

Market Cap: NOK 181.5m

Operates as a clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway.

TherapeuticsMD

Market Cap: US$16.9m

Operates as a pharmaceutical royalty company in the United States.

BDH Industries

Market Cap: ₹1.4b

Engages in the manufacture and sale of therapeutic formulations covering a range of pharmaceuticals in India.

Otsuka Pakistan

Market Cap: PK₨4.5b

Manufactures, markets, and distributes intravenous infusions in Pakistan and Afghanistan.